TMEM66 inhibitors belong to a distinct chemical class that targets the transmembrane protein 66 (TMEM66), a protein encoded by the TMEM66 gene. TMEM66, also known as leucine-rich repeat-containing protein 50 (LRRC50), plays a pivotal role in cellular processes, particularly in the context of ciliary and flagellar function. This protein is recognized for its involvement in the assembly and maintenance of the axonemal dynein arms within cilia and flagella, essential structures for cellular motility and signaling. The inhibition of TMEM66 appears to disrupt these intricate processes, leading to altered ciliary and flagellar dynamics. Consequently, the development of TMEM66 inhibitors represents a strategic approach to modulate cellular functions related to cilia and flagella, providing a potential avenue for investigating the physiological and molecular implications of TMEM66 in various biological contexts.
The chemical structures of TMEM66 inhibitors are characterized by their ability to selectively interact with the TMEM66 protein, hampering its normal function. These inhibitors may act through competitive binding at specific binding sites on the TMEM66 protein, thereby impeding its interactions with other cellular components critical for ciliary and flagellar assembly. Understanding the structural features and mechanisms of action of TMEM66 inhibitors is crucial for unraveling the intricacies of ciliary and flagellar biology and may have implications for a broader understanding of cellular processes related to motility and signaling.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Calcium channel blocker that reduces calcium influx, indirectly affecting proteins modulated by calcium levels. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
Ryanodine receptor antagonist; by reducing calcium release from the sarcoplasmic reticulum, it could indirectly affect TMEM66-related calcium signaling. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Another calcium channel blocker that could diminish calcium entry, potentially influencing TMEM66 activity. | ||||||
TMB-8 • HCl | 53464-72-5 | sc-3522 sc-3522A | 10 mg 50 mg | $43.00 $129.00 | 10 | |
Inhibits intracellular calcium release, which may modify the function of calcium-binding proteins like TMEM66. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
Modulates calcium signaling through various channels, potentially altering the activity of calcium-dependent proteins. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
SERCA pump inhibitor that prevents calcium sequestration, potentially impacting proteins that bind calcium in the sarcoplasmic reticulum. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Modifies the function of ryanodine receptors, influencing calcium flux and potentially the role of TMEM66 in calcium signaling. | ||||||
Amlodipine | 88150-42-9 | sc-200195 sc-200195A | 100 mg 1 g | $74.00 $166.00 | 2 | |
Calcium channel blocker, could alter the calcium-dependent processes involving TMEM66. | ||||||
ML-9 | 105637-50-1 | sc-200519 sc-200519A sc-200519B sc-200519C | 10 mg 50 mg 100 mg 250 mg | $112.00 $449.00 $673.00 $1224.00 | 2 | |
Inhibits myosin light chain kinase, affecting muscle contraction and possibly calcium signaling related to TMEM66. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Calcium chelator that can lower intracellular calcium concentrations, influencing TMEM66 activity. | ||||||